Rich Pharmaceuticals, Inc. is pleased to announce the appointment of Professor Richard L. Chang to the Company's Medical Advisory Board. Chang is the inventor and patent holder for indications presently being developed by Rich Pharmaceuticals. During his distinguished career, he has authored 121 peer-reviewed journal publications and has presented over 150 scientific abstracts across the world in the field of cancer research.

Revance Therapeutics, Inc., a specialty biopharmaceutical company that develops botulinum toxin products for use in aesthetic and therapeutic indications, recently announced that Mark A. Prygocki has been appointed to its board of directors and as the chair of its audit committee.

Bioelements is excited to announce that it will expand distribution of its complete line of professional skin care products with Raylon. This new expansion includes 13 professional-only Raylon stores and professional beauty salon and spa sales consultants covering Pennsylvania, Delaware and New Jersey. It will allow Bioelements to provide the best in professional skin care products, services, and education to previously unavailable areas.

Dr. med. Christine Schrammek-Drusio was born in Poland. At the age of 11, she relocated to Essen, Germany, where her mother, Christine Schrammek, laid the foundation for the company. Inspired by her mother, Christine graduated from her medical studies with a focus on dermatology. She then worked in a skin clinic for several years before opening her own practice. During that time, she was already…

For the first time, the National Psoriasis Foundation (NPF) has appointed industry scientists – Prisca Honoré, PharmD, Ph.D. of AbbVie; David M. Lee, M.D., Ph.D, of Novartis; Lotus Mallbris, M.D., Ph.D. of Pfizer; and Chris Russell, Ph.D., of Amgen – to its Scientific Advisory Committee to help guide its research activities. The selection of industry scientists advances the Psoriasis Foundation’s ongoing efforts to include a…

ZO Skin Health, Inc. and Cellogique Corporation recently launched the ZO® Medical product line to the Middle East region at The Dubai World Dermatology & Laser Conference & Exhibition – Dubai Derma. Developed by internationally renowned, board certified dermatologist, Dr. Zein Obagi, ZO® Skin Health and ZO® Medical products represent his new thinking and skin health principles.

With the goal of funding 50,000 women entrepreneurs around the world through the company’s philanthropic arm, FITE, Dermalogica teams around the world raised awareness surrounding women’s issues and raised funds in support of International Women’s Day. In the United States, team members at Dermalogica’s concept spaces and at locations for The International Dermal Institute (IDI) made FITE donations for every retail purchase, including online, made…

Syneron Medical Ltd., a global market leader in the aesthetic medical device marketplace, recently announced that it has received the United States Food and Drug Administration (FDA) 510(k) clearance to market the UltraShape™ System for non-invasive reduction of abdominal circumference via fat cell destruction.